Clinical Trial Update: Casodex/Zoladex Biomarkers in Localised Prostate Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial in localized prostate cancer evaluating biomarkers in patients treated with Casodex and Zoladex has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Casodex (bicalutamide)
• Zoladex (goserelin)

Snippet

Sponsor: Tampere University | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED